AbbVie’s Elahere wins European approval for certain ovarian cancers
The decision in Europe follows an approval granted by the US Food and Drug Administration (FDA) in March this year.
The decision in Europe follows an approval granted by the US Food and Drug Administration (FDA) in March this year.
What's Your Reaction?
